Investigational Site Number : 7240008

Málaga 29010

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer Metastatic, Polyneuropathy, Inflammatory Demyelinating, Chronic, Type 2 Diabetes Mellitus

Studies at this site

• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period — Completed